{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:48:51Z","timestamp":1782377331818,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjcard.2026.04.040","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:14:50Z","timestamp":1777734890000},"page":"76-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipid Profiles and LDL Subfractions in Patients With Symptomatic Peripheral Artery Disease: A Pilot Study"],"prefix":"10.1016","volume":"271","author":[{"given":"Rahul","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristen","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria L.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-2605","authenticated-orcid":false,"given":"Shirling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.04.040_bib0001","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjcard.2022.09.018","article-title":"Prognostic impact of statins on patients with peripheral artery disease with elevated C-reactive protein levels","volume":"186","author":"Shibahashi","year":"2023","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.amjcard.2026.04.040_bib0002","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.amjcard.2009.12.054","article-title":"Comparison of effects of Statin use on mortality in patients with peripheral arterial disease with versus without elevated C-reactive protein and D-dimer levels","volume":"105","author":"Vidula","year":"2010","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.amjcard.2026.04.040_bib0003","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.amjcard.2014.01.405","article-title":"Comparison of lipid management in patients with coronary versus peripheral arterial disease","volume":"113","author":"Sharma","year":"2014","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.amjcard.2026.04.040_bib0004","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.amjcard.2026.04.040_bib0005","first-page":"1141","article-title":"Coronary and peripheral artery plaques: do differences in plaque characteristics translate to differences in lipid management?","volume":"68","author":"Tsai","year":"2020","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"issue":"1","key":"10.1016\/j.amjcard.2026.04.040_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(96)06012-1","article-title":"Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study","volume":"129","author":"Powell","year":"1997","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.amjcard.2026.04.040_bib0007","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/clc.23241","article-title":"Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: a large administrative retrospective analysis","volume":"42","author":"Toth","year":"2019","journal-title":"Clin Cardiol"},{"issue":"5","key":"10.1016\/j.amjcard.2026.04.040_bib0008","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.3390\/ijms24054268","article-title":"Cholesterol remnants, triglyceride-rich lipoproteins and cardiovascular risk","volume":"24","author":"Baratta","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.amjcard.2026.04.040_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9149(99)00308-2","article-title":"Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease","volume":"83","author":"Brewer","year":"1999","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.amjcard.2026.04.040_bib0010","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.jacc.2020.10.029","article-title":"Remnant cholesterol and atherosclerotic cardiovascular disease risk","volume":"76","author":"Burnett","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.amjcard.2026.04.040_bib0011","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.amjcard.2026.04.040_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.040_bib0013","doi-asserted-by":"crossref","first-page":"101397","DOI":"10.1016\/j.ajpc.2025.101397","article-title":"Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes","volume":"25","author":"Amamoo","year":"2026","journal-title":"Am J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.amjcard.2026.04.040_bib0014","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2018-01656","article-title":"Association between triglyceride level and glycemic control among insulin-treated patients with type 2 diabetes","volume":"104","author":"Zheng","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2026.04.040_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2023.04.017","article-title":"Role of lipoprotein A in lower extremity peripheral artery disease","volume":"198","author":"Banerjee","year":"2023","journal-title":"Am J Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926002778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926002778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:17:48Z","timestamp":1782375468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926002778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"alternative-id":["S0002914926002778"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.04.040","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid Profiles and LDL Subfractions in Patients With Symptomatic Peripheral Artery Disease: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}